Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Medivation, Inc.

http://www.medivation.com/

Latest From Medivation, Inc.

Coronavirus Update: Gilead To Meet Global Remdesivir Demand By October

Ramp-up is possible thanks to increased internal capacity and network of voluntary licensing partners including Mylan, Cipla and Dr Reddy's.

Coronavirus COVID-19 Deals

Coronavirus Update: Roche's Actemra Fails In Phase III COVID Study

Disappointment as Roche/Chugai antibody tocilizumab misses most endpoints. 

Coronavirus COVID-19 Clinical Trials

EU Takes Over COVID-19 Vaccine Negotiations, But Lags Behind US

A quartet of EU countries started vaccine procurement talks with AstraZeneca, but are now allowing the European Commission to take over negotiations.

Coronavirus COVID-19 Europe

Finance Watch: With Four More IPOs, July May Match Or Exceed June’s 14

Public Company Edition: iTeos, Annexon, Nurix and Inozyme went public on 23 July and now CureVac had added its name to the IPO queue for what could be a large offering. Also, BioNTech raises $511.5m as COVID-19 vaccine progresses and PTC gets $650m from sale of risdiplam royalties. 

Financing Business Strategies
See All

Company Information

UsernamePublicRestriction

Register